Croissy-Beaubourg, April 15, 2022 3:00 p.m. CEST – THERADIAG (ISIN: FR0004197747, Mnemonic: ALTER), a company specializing in in vitro diagnostics and theranostics, announces the holding of its Combined General Meeting on May 5, 2022 at 3:00 p.m. in the premises of the Cabinet Fieldfisher, 48 rue Cambon, 75001 Paris and the terms of this holding, as well as the vote available by internet via the VOTACCESS platform.
If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected]